Remifentanil analgesia during external cephalic version for breech presentation in nulliparous women at term: A randomized controlled trial

Zhi-Hong Wang, Yi Yang, Gui-Ping Xu, Zhi-Hong Wang, Yi Yang, Gui-Ping Xu

Abstract

Background: The aim of the study was to assess the efficacy and safety of remifentanil for pain relief during external cephalic version (ECV) for breech presentation in nulliparous women at term.

Methods: A total of 144 nulliparous women with singleton breech presentation were randomly divided into the intervention group and the placebo group, with 72 subjects in each group. The subjects in the intervention group received remifentanil (infused at 0.1 μg kg min with demand boluses of 0.1 μg/kg), whereas those in the placebo group were given saline placebo. This study was conducted from May 2013 to April 2016. The outcomes measures include pain (measured with the visual analog scale, VAS), success rate of ECV, maternal satisfaction for ECV, and adverse events.

Results: A total of 137 participants completed the study. The intervention with remifentanil showed greater efficacy than did placebo in decreasing the VAS score immediately after ECV (intervention group 4.3 ± 2.2 vs placebo group 6.4 ± 2.5, P < 0.01). A significant difference in the ECV success rate was also found between the 2 groups (intervention group 56.9% vs placebo group 38.9%, P = 0.03). In addition, a significant difference in the satisfaction score was also detected (intervention group 9.3 ± 0.9 vs placebo group 6.7 ± 1.2, P < 0.01). The observed adverse events were similar between the 2 groups.

Conclusion: This study shows that remifentanil could decrease pain, improve the ECV success rate, and improve satisfaction in nulliparous women at term during the period of ECV. Furthermore, it is also well tolerated with few adverse events.

Conflict of interest statement

The authors have no funding and conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Flow of participants through the trial.

References

    1. Kok M, Cnossen J, Gravendeel L, et al. Ultrasound factors to predict the outcome of external cephalic version: a meta-analysis. Ultrasound Obstet Gynecol 2009;33:76–84.
    1. American College of Obstetricians and Gynecologysts. External cephalic version. ACOG Practice Bulletin No. 13, February 2000.
    1. Collaris RJ, Oei SG. External cephalic version: a safe procedure? A systematic review of version-related risks. Acta Obstet Gynecol Scand 2004;83:511–8.
    1. Zhao E, Wei Y, Zhang Y, et al. A comparison of transthroracic echocardiograpy and transcranial Doppler with contrast agent for detection of patent foramen ovale with or without the valsalva maneuver. Medicine (Baltimore) 2015;94:e1937.
    1. Burgos J, Melchor JC, Cobos P, et al. Ana’lisis del dolor en la versio’n externa. Prog Obstet Ginecol 2009;52:557–61.
    1. Cluver C, Gyte GM, Sinclair M, et al. Interventions for helping to turn term breech babies to head first presentation when using external cephalic version. Cochrane Database Syst Rev 2015;2:CD000184.
    1. Macarthur AJ, Gagnon S, Tureanu LM, et al. Anesthesia facilitation of external cephalic version: a meta analysis. Am J Obstet Gynecol 2004;191:1219–24.
    1. Liu X, Xue A. A randomized trial of remifentanil for analgesia in external cephalic version for breech presentation. Medicine (Baltimore) 2016;95:e5483.
    1. Weiniger CF, Ginosar Y, Elchalal U, et al. External cephalic version for breech presentation with or without spinal analgesia in nulliparous women at term: a randomized controlled trial. Obstet Gynecol 2007;110:1343–50.
    1. Heesen M, Klöhr S, Hofmann T, et al. Maternal and foetal effects of remifentanil for general anaesthesia in parturients undergoing caesarean section: a systematic review and meta-analysis. Acta Anaesthesiol Scand 2013;57:29–36.
    1. Schnabel A, Hahn N, Broscheit J, et al. Remifentanil for labour analgesia: a meta-analysis of randomised controlled trials. Eur J Anaesthesiol 2012;29:177–85.
    1. Volmanen P, Palomäki O, Ahonen J. Alternatives to neuraxial analgesia for labor. Curr Opin Anaesthesiol 2011;24:235–41.
    1. Fok WY, Chan LW, Leung TY, et al. Maternal experience of pain during external cephalic version at term. Acta Obstet Gynecol Scand 2005;84:748–51.
    1. Muñoz H, Guerra S, Perez-Vaquero P, et al. Remifentanil versus placebo for analgesia during external cephalic version: a randomised clinical trial. Int J Obstet Anesth 2014;23:52–7.
    1. Burgos J, Pijoan JI, Osuna C, et al. Increased pain relief with remifentanil does not improve the success rate of external cephalic version: a randomized controlled trial. Acta Obstet Gynecol Scand 2016;95:547–54.
    1. Sultan P, Carvalho B. Neuraxial blockade for external cephalic version: a systematic review. Int J Obstet Anesth 2011;20:299–306.
    1. Goetzinger KR, Harper LM, Tuuli MG, et al. Effect of regional anesthesia on the success rate of external cephalic version: a systematic review and meta-analysis. Obstet Gynecol 2011;118:1137–44.
    1. Lavoie A, Guay J. Anesthetic dose neuraxial blockade increases the success rate of external fetal version: a metaanalysis. Can J Anaesth 2010;57:408–14.
    1. Weiniger CF. Analgesia/anesthesia for external cephalic version. Curr Opin Anaesthesiol 2013;26:278–87.
    1. O’Brien JA, Adashi EY. Coming out ahead: the cost effectiveness of external cephalic version using spinal anesthesia. Isr J Health Policy Res 2014;3:6.
    1. Rozenberg P, Goffinet F, de Spirlet M, et al. External cephalic version with epidural anaesthesia after failure of a first trial with betamimetics. BJOG 2000;107:406–10.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren